Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases
Abstract Purpose To report the feasibility and short-term safety of off-label intravitreal eculizumab as a complement-inhibition strategy for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), based on two clinical cases. Case reports Two pseudophakic patients with progress...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-04-01
|
| Colecção: | International Journal of Retina and Vitreous |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s40942-026-00842-1 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|